Health & Beauty

According to the news from Tianjin Port Free Trade Zone, the rapid detection kit for novel coronavirus antigen (self-test payment for front nasal swab) independently developed by Tianjin hongyutai Biotechnology Co., Ltd., an enterprise in the zone, has obtained the certification of the EU notified body. The product meets the EU market standards and can be sold in EU Member States and other countries that recognize the EU standards.

It is understood that the novel coronavirus antigen rapid detection kit developed by hongyutai biology adopts the principle of colloidal immune gold chromatography. Individuals can collect samples for detection without other auxiliary equipment. It can be used in other scenarios such as home self-test and social health detection, and can also be sold on retailers' supermarkets and online sales platforms. Compared with nucleic acid detection, antigen detection time is short and coverage is high, which meets the needs of epidemic prevention and control at home and provides more convenient and sufficient backup resources for global anti epidemic.

Hongyutai biology settled in the civil aviation science and technology industrialization base of Tianjin Port Free Trade Zone Airport Economic Zone in August, 2020. "Driven by such positive factors as the good policy support of the bonded zone, geographical advantages and the company's internal strategic management, hongyutai biology has been able to develop healthily and rapidly." Wu Bo, the head of hongyutai biology, said that since the end of 2020, hongyutai biology has obtained CE certificates for three products related to Xinguan detection and obtained the white list of the Ministry of Commerce for export, when the epidemic situation is seriously spreading and it is in urgent need of detection kits, it has sent tens of millions of novel coronavirus detection kits to Germany, the United Kingdom, Italy, Japan, Thailand, Indonesia and other countries to help the global epidemic prevention of Xinguan, Since then, hongyutai brand has emerged in the overseas market.

As an important branch of medical devices, in vitro diagnosis (IVD) has developed rapidly under the background of population aging, the growth of medical service demand and the general trend of domestic production. As an emerging enterprise in the in vitro diagnosis industry, hongyutai biology has also made gratifying progress in in in vitro diagnosis projects such as immunofluorescence and chemiluminescence, in addition to developing a triple rapid detection kit for novel coronavirus igm/igg/ neutralizing antibody and a rapid detection kit for novel coronavirus antigen.